Send us Fan Mail

Surfing NASH returns to review the 2023 Innovations in NAFLD Care Workshop (INCBCN) which concluded on 27 May in Barcelona. Conference founders and directors Jeff Lazarus and Jörn Schattenberg discuss highlights and takeaways of the event with Louise Campbell and Roger Green.

This conversation starts with Jeff commenting on patient needs and a specific question which Alina Allen raised around whether people should be diagnosed earlier and do the harms outweigh the benefits? Jeff notes that this is a significant mistake, recalling his own experiences with the Hep-C community. The group next detours briefly into the impact that the FDA ADCOM on obeticholic acid has on all of these issues before shifting to discuss the second day. Jörn talks about the idea that while there were a limited number of posters at the meeting, the posters that were there were excellent and engaging in the way that researchers could discuss them in detail. Jeff summarizes Alina Allen's talk about how to use AI and diagnostics. Jörn points out that we need more standardized patient reports if we were to use this data in AI because the data has to be standardized to take advantage of it. The end of the session takes an entertaining twist, so listen on to find out more.

If you have questions or interest around the Innovations in NAFLD Care Workshop 2023, we kindly ask that you submit reviews wherever you download our discussions. Alternatively, you can write to us directly at [email protected].

Stay Safe and Surf On!